Investor Relations

IR Overview

The Company is committed to treating all shareholders fairly and equitably and keeping all shareholders and stakeholders promptly informed of its corporate activities. 

The Company has put in place an investor relations (IR) policy which sets out the mechanism of communication between the shareholders and the Company.

IR Contact

The IR Team of the Company comprises the following Executive Directors and Executive Officers:
Cheng Shoong Tat
(Chairman and CEO)

Dr Ong Fung Chin
(President and Chief Medical Officer)

Wu Peicong
(Chief Financial Officer)

Ong Huey Jwu
(General Manager (Singapore))

Anbhu Selvem
(Senior Accounting Manager)

Shareholders and the investment community can contact the Company’s IR Team via:
Scroll to Top